Leo Hofland
Leo Hofland
Erasmus MC
Verified email at erasmusmc.nl
TitleCited byYear
Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
EP Krenning, DJ Kwekkeboom, WH Bakker, WAP Breeman, PPM Kooij, ...
European journal of nuclear medicine 20 (8), 716-731, 1993
SWJ Lamberts, AJ Van der Lely, WW de Herder, LJ Hofland
New England Journal of Medicine 334 (4), 246-254, 1996
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
BMK Biller, AB Grossman, PM Stewart, S Melmed, X Bertagna, J Bertherat, ...
The Journal of Clinical Endocrinology & Metabolism 93 (7), 2454-2462, 2008
Osteoporosis in men: an Endocrine Society clinical practice guideline
NB Watts, RA Adler, JP Bilezikian, MT Drake, R Eastell, ES Orwoll, ...
The Journal of Clinical Endocrinology & Metabolism 97 (6), 1802-1822, 2012
The pathophysiological consequences of somatostatin receptor internalization and resistance
LJ Hofland, SWJ Lamberts
Endocrine reviews 24 (1), 28-47, 2003
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
WH Bakker, R Albert, C Bruns, WAP Breeman, LJ Hofland, P Marbach, ...
Life sciences 49 (22), 1583-1591, 1991
Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes
C Gauna, PJD Delhanty, LJ Hofland, JA Janssen, F Broglio, RJM Ross, ...
The Journal of Clinical Endocrinology & Metabolism 90 (2), 1055-1060, 2005
Cultural distance, political risk, or governance quality? Towards a more accurate conceptualization and measurement of external uncertainty in foreign entry mode research
AHL Slangen, RJM Van Tulder
International business review 18 (3), 276-291, 2009
Comparison of 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy
M de Jong, WAP Breeman, WH Bakker, PPM Kooij, BF Bernard, ...
Cancer Research 58 (3), 437-441, 1998
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity
C Gauna, FM Meyler, J Janssen, PJD Delhanty, T Abribat, ...
The Journal of Clinical Endocrinology & Metabolism 89 (10), 5035-5042, 2004
The medical treatment of Cushing’s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery
R Pivonello, MC De Martino, P Cappabianca, M De Leo, A Faggiano, ...
The Journal of Clinical Endocrinology & Metabolism 94 (1), 223-230, 2009
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5
LJ Hofland, J van der Hoek, R Feelders, MO van Aken, PM van Koetsveld, ...
European Journal of Endocrinology 152 (4), 645-654, 2005
Dopamine receptor expression and function in corticotroph pituitary tumors
R Pivonello, D Ferone, WW De Herder, JM Kros, ML Del Basso De Caro, ...
The Journal of Clinical Endocrinology & Metabolism 89 (5), 2452-2462, 2004
Parallel in Vivo and in Vitro Detection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis …
The Journal of Clinical Endocrinology & Metabolism 71 (3), 566-574, 1990
Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease
RA Feelders, C de Bruin, AM Pereira, JA Romijn, RT Netea-Maier, ...
New England Journal of Medicine 362 (19), 1846-1848, 2010
Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
WW De Herder, LJ Hofland, AJ van der Lely, SWJ Lamberts
Endocrine-related cancer 10 (4), 451-458, 2003
The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro
LJ Hofland, J van der Hoek, PM van Koetsveld, WW de Herder, ...
The Journal of Clinical Endocrinology & Metabolism 89 (4), 1577-1585, 2004
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans
F Broglio, P Koetsveld, A Benso, C Gottero, F Prodam, M Papotti, ...
The Journal of Clinical Endocrinology & Metabolism 87 (10), 4829-4832, 2002
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients
J van der Hoek, WW de Herder, RA Feelders, AJ van der Lely, ...
The Journal of Clinical Endocrinology & Metabolism 89 (2), 638-645, 2004
Ghrelin drives GH secretion during fasting in man
A Muller, S Lamberts, L Hofland, M Bidlingmaier, CJ Strasburger, E Ghigo, ...
European Journal of Endocrinology, 2002
The system can't perform the operation now. Try again later.
Articles 1–20